Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of Lsta1 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Lisata Therapeutics和齐鲁制药宣布齐鲁在中国开展的针对转移性胰腺导管腺癌患者Lsta1的2期试验中首位患者接受治疗
Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of Lsta1 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Lisata Therapeutics和齐鲁制药宣布齐鲁在中国开展的针对转移性胰腺导管腺癌患者Lsta1的2期试验中首位患者接受治疗
使用浏览器的分享功能,分享给你的好友吧